At the news
? NEUTRALIMPACT 2/10 6-K filed Nov 5, 2026 at 13:06 ET
Novo Nordisk filed a Form 6-K disclosing a share sale by Executive Vice President and CSO Martin Holst Lange. He sold 12,000 B shares at DKK 285.00 per share, for a total of DKK 3,420,000. This is a routine insider sale disclosure with no material financial impact.
- Martin Holst Lange (EVP, R&D and CSO) sold 12,000 Novo Nordisk B shares
- Sale price: DKK 285.00 per share
- Total proceeds: DKK 3,420,000
- Transaction date: November 4, 2026
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access